171 related articles for article (PubMed ID: 29895451)
1. Second primary malignancies after high-dose-rate
Janulionis E; Samerdokiene V; Valuckas KP; Atkocius V; Rivard MJ
Brachytherapy; 2018; 17(5):768-774. PubMed ID: 29895451
[TBL] [Abstract][Full Text] [Related]
2. Second primary malignancies after radiotherapy including HDR (252)Cf brachytherapy for cervical cancer.
Samerdokiene V; Valuckas KP; Janulionis E; Atkocius V; Rivard MJ
Brachytherapy; 2015; 14(6):898-904. PubMed ID: 26194049
[TBL] [Abstract][Full Text] [Related]
3. Long-term results for Stage IIIB cervical cancer patients receiving external beam radiotherapy combined with either HDR (252)Cf or HDR (60)Co intracavitary brachytherapy.
Ulinskas K; Janulionis E; Valuckas KP; Samerdokiene V; Atkocius V; Rivard MJ
Brachytherapy; 2016; 15(3):353-360. PubMed ID: 26996594
[TBL] [Abstract][Full Text] [Related]
4. Low-dose-rate californium-252 neutron intracavitary afterloading radiotherapy combined with conformal radiotherapy for treatment of cervical cancer.
Zhang M; Xu HD; Pan SD; Lin S; Yue JH; Liu JR
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):966-71. PubMed ID: 22138462
[TBL] [Abstract][Full Text] [Related]
5. [Follow-up study of clinical effects of californium-252 neutron intracavitary radiotherapy and external beam radiotherapy in endometrial cancer].
Lei X; Shan JL; Tang C; Zhao KW
Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):733-6. PubMed ID: 18307897
[TBL] [Abstract][Full Text] [Related]
6. A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations.
Brown AP; Neeley ES; Werner T; Soisson AP; Burt RW; Gaffney DK
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):127-35. PubMed ID: 19910129
[TBL] [Abstract][Full Text] [Related]
7. Second malignancies following conventional or combined ²⁵²Cf neutron brachytherapy with external beam radiotherapy for breast cancer.
Valuckas KP; Atkocius V; Kuzmickiene I; Aleknavicius E; Liukpetryte S; Ostapenko V
J Radiat Res; 2013 Sep; 54(5):872-9. PubMed ID: 23397075
[TBL] [Abstract][Full Text] [Related]
8. New understanding from Cf brachytherapy trials and considerations for neutron therapy of bulky gyn carcinoma for future.
Maruyama Y; Mesina J; Yudelev M; Wierzbicki J; Deppe G; Porter AT
Strahlenther Onkol; 1994 May; 170(5):253-63. PubMed ID: 8197547
[TBL] [Abstract][Full Text] [Related]
9. Hypoxic versus normoxic external-beam irradiation of cervical carcinoma combined with californium-252 neutron brachytherapy. Comparative treatment results of a 5-year randomized study.
Tacev T; Vacek A; Ptácková B; Strnad V
Strahlenther Onkol; 2005 May; 181(5):273-84. PubMed ID: 15900423
[TBL] [Abstract][Full Text] [Related]
10. Early-stage esophageal squamous cell carcinoma treated with californium-252 neutron brachytherapy: clinical report on 16 cases.
Liu H; Wang Q; Jia X; Liu B; Wang CK
Tumori; 2013; 99(2):172-5. PubMed ID: 23748810
[TBL] [Abstract][Full Text] [Related]
11. Image-guided high-dose-rate intracavitary brachytherapy in the treatment of medically inoperable early-stage endometrioid type endometrial adenocarcinoma.
Jordan SE; Micaily I; Hernandez E; Ferriss JS; Miyamoto CT; Li S; Micaily B
Brachytherapy; 2017; 16(6):1144-1151. PubMed ID: 28958736
[TBL] [Abstract][Full Text] [Related]
12. Californium-252 neutron brachytherapy combined with external beam radiotherapy for esophageal cancer: long-term treatment results.
Liu H; Wang Q; Wan X; Jia X; Liu B; Wang CK
Brachytherapy; 2014; 13(5):514-21. PubMed ID: 24818780
[TBL] [Abstract][Full Text] [Related]
13. Long-term results of high-dose-rate brachytherapy and external-beam radiotherapy in the primary treatment of endometrial cancer.
Inciura A; Atkocius V; Juozaityte E; Vaitkiene D
J Radiat Res; 2010; 51(6):675-81. PubMed ID: 21116100
[TBL] [Abstract][Full Text] [Related]
14. Clinical assessment of 252Californium neutron intracavitary brachytherapy using a two-channel Y applicator combined with external beam radiotherapy for endometrial cancer.
Zhou Q; Tang C; Zhao KW; Xiong YL; Chen S; Xu WJ; Lei X
Clinics (Sao Paulo); 2016 Jan; 71(1):10-6. PubMed ID: 26872078
[TBL] [Abstract][Full Text] [Related]
15. Triple-tandem high-dose-rate brachytherapy for early-stage medically inoperable endometrial cancer: Initial report on acute toxicity and dosimetric comparison to stereotactic body radiation therapy.
Kauffmann G; Wu T; Al-Hallaq H; Hasan Y
Brachytherapy; 2017; 16(1):141-146. PubMed ID: 27866953
[TBL] [Abstract][Full Text] [Related]
16. Californium-252 neutron brachytherapy combined with external pelvic radiotherapy plus concurrent chemotherapy for cervical cancer: a retrospective clinical study.
Qian S; Ye L; Tian YH; Wang LG; Huang ZP; Li F; Hou B; Song N; Chen J; Liu Y; Liu X; Zhou T
Chin J Cancer; 2017 Feb; 36(1):24. PubMed ID: 28245859
[TBL] [Abstract][Full Text] [Related]
17. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
Alektiar KM; Venkatraman E; Chi DS; Barakat RR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
[TBL] [Abstract][Full Text] [Related]
18. Californium versus cobalt brachytherapy combined with external-beam radiotherapy for IIB stage cervical cancer: long-term experience of a single institute.
Janulionis E; Valuckas KP; Liukpetryte S; Samerdokiene V; Atkocius V
J Contemp Brachytherapy; 2015 Oct; 7(5):346-51. PubMed ID: 26622239
[TBL] [Abstract][Full Text] [Related]
19. [Clinical analysis of combination of (252)Cf neutron intracavitary brachytherapy and external beam radiotherapy for 110 cervical cancer patients].
Bu J; Li R; Song W; Cao JX; Wang YX
Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):619-21. PubMed ID: 21122417
[TBL] [Abstract][Full Text] [Related]
20. [Radiotherapy alone in endometrial neoplasms. The authors' own experience].
Fusco V; Troiano M; Corsa P; Raguso A; Lioce M; Lauriola P; Parisi S
Radiol Med; 1998 Jun; 95(6):640-6. PubMed ID: 9717549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]